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F2-isoprostanes mediate high glucose-induced TGF-b synthesis serious long-term complications for the individual dia-
and glomerular proteinuria in experimental type I diabetes. betic patient. More than one third of patients who de-
Background. The recently discovered arachidonic acid de- velop chronic renal failure in the United States do sorivatives, isoprostanes, are increased in pathological conditions
because of diabetes [1].associated with oxidative stress, such as diabetes. No role has
Diabetic nephropathy is characterized by the earlyyet been described for isoprostanes during the development
of diabetic nephropathy. Cell culture in high ambient glucose appearance of hypertrophy of both glomerular and tubu-
has been used as a model in elucidating cellular mechanisms lar structures, the subsequent development of thickened
underlying diabetic nephropathy. Among the growth factors glomerular and tubular membranes associated with en-involved in the effect of high glucose, transforming growth
hanced glomerular permeability to albumin, and thefactor-b (TGF-b) has been described as playing a key role in
eventual progressive accumulation of extracellular ma-the development of nephropathy.
Methods. Streptozotocin-induced diabetic rats were supple- trix components in the glomerular mesangium and the
mented in their diet with the antioxidant vitamin E (1000 U/kg tubulointerstitium in susceptible patients [1].
diet). Blood and urine samples were taken to determine renal Cell culture has been widely used as an in vitro modelfunction and isoprostane concentration, as determined by gas
to assess the effects of hyperglycemia on cell functions.chromatography/mass spectrometry. Glomerular mesangial and
Elevated ambient glucose influences renal cell growthendothelial cells were cultured in high ambient glucose to de-
termine the synthesis of isoprostanes and the role of isopros- and extracellular matrix metabolism [2–4]. High glucose
tanes in high glucose-induced synthesis of TGF-b. stimulates proximal tubular cell hypertrophy and pro-
Results. Streptozotocin-induced diabetic rats had marked in-
duction of collagen types I and IV [5]. High glucosecreases in plasma levels and urinary excretion rates of F2-isopros-
also modulates mesangial cell growth and stimulates thetanes. Dietary supplementation with vitamin E normalized
(plasma) and reduced (urine) isoprostane levels and, surpris- production of fibronectin and collagen [3, 4]. Both in-
ingly, improved proteinuria and blood urea nitrogen (BUN) creased synthesis and decreased degradation have been
levels. High ambient glucose increased F2-isoprostane synthesis proposed to explain extracellular matrix accumulation
in glomerular endothelial and mesangial cells in culture. Incu-
in the diabetic kidney [6, 7].bation of glomerular cells with F2-isoprostanes stimulated the
It now appears that the hypertrophic and proscleroticproduction of TGF-b.
Conclusions. Increased F2-isoprostane synthesis during dia- effects of high glucose concentrations on glomerular
betes appears to be responsible in part for the increase in renal mesangial cells are mediated by autocrine production
TGF-b, a well-known mediator of diabetic nephropathy. and activation of transforming growth factor-b (TGF-b)
[6]. Thus, TGF-b mRNA expression and bioactivity are
increased after exposure of mesangial cells to high glu-
Diabetic nephropathy is the number one cause of renal cose, and the use of specific antibodies against TGF-b
failure in the industrialized world and one of the most reduces glucose-induced synthesis of collagen, fibronec-
tin, and mesangial proteoglycans [4, 8, 9]. Increased lev-
els of TGF-b have also been found in kidneys of diabeticKey words: antioxidants, vitamin E, diabetic nephropathy, epi-prosta-
glandins, transforming growth factor-b. animals [10]. On the other hand, the use of neutralizing
monoclonal anti–TGF-b antibodies significantly attenu-Received for publication October 8, 1999
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anisms underlying high glucose-induced stimulation of Antioxidant effect has been also studied with mesan-
gial cells in culture under high glucose [30]. The additionTGF-b expression are not clear, although it has been
suggested that activation of protein kinase C (PKC) may of vitamin E partially inhibits the increased synthesis of
fibronectin observed in response to high ambient glucose,be involved [12, 13]. Recently, it has been described that
high ambient glucose activates TGF-b1 expression in indicating a role of oxidant stress in the synthesis of extra-
cellular matrix components [30]. In this sense, it has beenmesangial cells via a transcriptional mechanism that in-
volves glucose response elements located in the TGF-b reported that high ambient glucose increases isoprostane
production in smooth muscle cells [31]. No data, how-gene promoter [14].
It has been suggested that oxidative stress plays a ever, are available regarding the effect of high glucose
on the synthesis of isoprostanes by renal glomerular cells,role in tissue damage associated with diabetes and that
peroxide formation is increased in elevated glucose solu- such as mesangial or endothelial cells, which are thought
to be the “initiators” of diabetic glomerulosclerosis.tions [15, 16]. The sources of oxygen-derived free radicals
in diabetes are not known, but it is possible that the As oxidant stress and lipid peroxidation have been
implicated in diabetes and its complications, includingorigin of these compounds are autoxidation of glucose,
eicosanoid intermediates of the cyclooxygenase path- increased extracellular matrix, our goal was to evaluate
the role of F2-isoprostanes during diabetic nephropathy.way, or mitochondrial products [15]. Hyperglycemia may
also lead to the attenuation of free-radical scavenging To achieve this goal, we determined urine and plasma
levels of isoprostanes in diabetic rats with and withoutmolecules [16]. In vitro, high ambient glucose can cause
lipid peroxidation in isolated rat glomeruli [17]. In vivo, antioxidant treatment, as well as the renal function of
diabetic rats treated with antioxidants. We also studiedstudies with streptozotocin-treated rats have shown that
dietary supplementation with antioxidants ameliorates the effect of high glucose on F2-isoprostane production
by glomerular mesangial and endothelial cells, as well asthe functional and long-term structural manifestations
of diabetic nephropathy [16]. the effect of F2-isoprostanes on the synthesis of TGF-b, a
mediator of extracellular matrix synthesis by these cells.In 1990, the existence of a novel class of eicosanoids
in normal human and rat plasma and urine was described:
Isoprostanes are oxidative products of arachidonic acid
METHODS
that did not belong to the classically identified enzymati-
In vivo studiescally derived products of arachidonate (cyclooxygenase,
lipoxygenase, or cytochrome-P-450) [18]. Their levels are Animal model. Male Sprague-Dawley rats weighing
275 to 300 g received streptozotocin (60 mg/kg bodygreatly increased in several conditions related to oxidant
stress and lipid peroxidation [19]. Since their discovery, weight) via a single intravenous injection. This model
develops glucosuria in 24 hours, and it is considered asmultiple actions have been defined for isoprostanes. Inter-
estingly, it was found that 8-iso-prostaglandin F2a (8-iso- a reliable model of type I diabetic nephropathy [32].
Animals received insulin daily (3 U/rat) to lower bloodPGF2a), one of the most abundant isoprostanes produced
in vivo, is an extremely potent renal vasoconstrictor, glucose. Animals were randomly assigned to two experi-
mental groups: normal diet or vitamin E-supplementedreducing glomerular filtration rate and renal blood flow
by 45%, with blood levels in the low nanomolar range diet (1000 U vitamin E/kg diet). The diet was prepared
daily to ensure homogeneous distribution of vitamin E[20]. 8-Iso-PGF2a has also been shown to induce mito-
genesis in vascular smooth muscle cells and endothelin- and to avoid it becoming rancid.
Rats were placed weekly into metabolic cages for 24-1 release from bovine aortic endothelial cells [21, 22].
Isoprostanes have been used as markers of oxidant hour urine collection for renal function and F2-isopros-
tane determination. Blood samples were also collectedstress in vivo, since their formation reflects the extent of
nonenzymatic lipid peroxidation. Their synthesis has been at that time.
Renal function was evaluated by determination of pro-demonstrated in pathological conditions in which free
radicals are thought to play a role, such as hepatorenal tein excretion and blood urea nitrogen (BUN) levels.
Proteinuria was measured by BioRad protein assay (Bio-syndrome [23], scleroderma [24], smoking [25], coronary
reperfusion injury [26], atherosclerosis [19], and diabetes Rad, Hercules, CA, USA). BUN levels were measured
using Beckman analyzers (BUN Analyzer II; Beckmanmellitus [27–29].
As mentioned previously in this article, increased iso- Instruments Inc., Brea, CA, USA).
Four weeks after the onset of diabetes, rats were sacri-prostane levels have been described in plasma and urine
from patients with type I and type II diabetes mellitus ficed, and a final blood sample was taken from the aorta
to determine the plasma F2-isoprostane concentration.[27, 28] and in animal models of diabetes [29]. However,
the increased production of isoprostanes is yet to be F2-isoprostane determination: Plasma and urine. F2-
isoprostanes in either plasma or urine were analyzed ac-associated with the loss of renal function observed in
diabetic nephropathy. cording to methods previously described [33]. Briefly,
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500 pg of a deuteriated 8-iso-PGF2a internal standard In vitro studies
(Cayman Chemical, Ann Arbor, MI, USA) were added Mesangial cell culture. Murine mesangial cells in cul-
to 1 mL of plasma or 0.2 mL urine. The mixture was ture were derived from glomeruli isolated from SJL/J
acidified to a pH of 3 and then purified by C18 and mice with a graded sieving technique and plated to ex-
Silica Sep-Pak (Waters Associates, Milford, MA, USA) plant. Mesangial cells were selected and subcultured ac-
extraction. The eluate was dried under N2 and converted cording to previously described criteria, including mor-
to a pentafluorbenzyl (PFB) ester derivative by reaction phology, ability to grow in medium containing D-valine
with PFB bromide. The material was subsequently fur- instead of L-valine, and the presence of cytoplasmic fil-
ther purified by thin layer chromatography (TLC) and aments, angiotensin II-binding capacity, and contractile
converted to the trimethylsilyl ether. F2-isoprostanes response to angiotensin II. Cells were stabilized by virus
were quantitated using gas chromatography/negative ion transformation with SV-40 and grown in Dulbecco’s modi-
chemical ionization mass spectrometry employing stable fied Eagle’s medium (DMEM) containing 5.5 mmol/L
isotope dilution methodology. The major ion generated glucose and 10% fetal calf serum (FCS) [2].
in this analysis was the M-PFB ion (M-181 ion), which Endothelial cell culture. Rat glomerular endothelial
had a charge-to-mass ratio of m/z 569 for endogenous cells were isolated from Sprague-Dawley rats. Kidneys
material and m/z 573 for the internal standard. F2-iso- from two female rats (100 to 120 g body weight) were
prostanes were quantitated by comparing the ratio of pooled, and glomeruli were isolated by differential siev-
endogenous material to standard [33]. ing. Glomeruli were treated with 0.1% collagenase for
Determination of TGF-b: Glomerular expression. 20 minutes (type IV collagenase; Sigma Chemical Co., St.
TGF-b expression in glomeruli from diabetic animals Louis, MO, USA) and washed twice in DMEM (GIBCO-
was determined by enzyme-linked immunosorbent assay BRL, Grand Island, NY, USA) with 10% FCS, 2 mmol/L
(ELISA; R&D Systems, Minneapolis, MN, USA) as fol- supplemental glutamine, 5 mg/mL insulin, 100 U/mL pen-
lows: Four weeks after the onset of diabetes, glomeruli icillin, and 100 mg/mL streptomycin. Fifty microliters of
were isolated from animals by mechanical sieving, sus- the cell suspension were then placed into each well of a
pended in lysis buffer [50 mmol/L HEPES, 1% Triton 96-well culture plate previously covered with fibronectin.
X-100, 50 mmol/L NaCl, 50 mmol/L NaF, 10 mmol/L The microtiter plates were screened by phase contrast
sodium pyrophosphate, 5 mmol/L ethylenediaminetetra- microscopy for the presence of cells with a cobblestone
acetic acid (EDTA), 1 mmol/L Na3BO4, 1 mmol/L phenyl- appearance, which is one of the characteristic features
methylsulfonyl fluoride, 10 mg/L aprotinin, and 10 mg/L of cultured endothelial cells. Cells fulfilling this criterion
leupeptin], and sonicated for 10 seconds. Cell debris was were cloned twice by limiting dilution, and a homogeneous
separated from solubilized protein by centrifugation at cell line was obtained. Cells were used between passages
1200 3 g for 10 minutes. Protein concentration in the 10 and 25. Cells were characterized by immunofluores-
supernatant was quantitated by the Bio-Rad protein cence following previously established criteria [34, 35].
assay technique (Bio-Rad, Melville, NY, USA). Super-
Cell culture experimentsnatants were then assayed by a sandwich ELISA according
to the manufacturer’s specifications. Acid activation of F2-isoprostane determination. The high ambient glucose
the samples was required in order to convert latent into effect was measured after either 24 hours or 14 days of
active TGF-b1 and to record detectable levels of total incubation.
(latent 1 active) TGF-b1. Samples were activated with For 24-hour effect, cells were transferred to 12-well
1 N HCl for 10 minutes at room temperature, followed plates and rested for 48 hours in DMEM with a D-glucose
by neutralization with 1 N NaOH. Samples were plated concentration of 100 mg/dL without any additional growth
on anti–TGF-b1-coated microtiter plates and incubated factors. Fresh serum-free DMEM with a glucose concen-
at room temperature for three hours. After vigorous wash- tration of 100 or 450 mg/dL was then added. For some
ing, wells are incubated with a second biotin conjugated experiments, the osmolarity of the medium containing
anti–TGF-b1 antibody, and the peroxidase action was ini- lower glucose concentrations was adjusted with D-man-
tiated. Bioactive levels of TGF-b1 prior to acidification nitol so that the final osmolarity of all media was equal.
were below the level of detectability by this assay (100 N-acetyl-cysteine (5 mmol/L) was used to determine
pg/mL). As there was an equilibrium between the latent high-glucose effect in low oxidative stress conditions.
and the active forms of TGF-b1, higher levels of total Indomethacin (0.1 mmol/L) was used to inhibit cyclooxy-
TGF-b1 (latent 1 active TGF-b1) implied that the active genases.
form of TGF-b1 was also increased. TGF-b1 levels in To study the long-term effect of high glucose, cells
samples were compared with known standards and were were cultured in presence of 100 or 450 mg/dL of glucose
read as ng/mL, and final concentrations are reported per for 14 days. Medium was changed every two to three
days. Cells were then transferred to 12-well plates. Aftertotal cell protein content (Bio-Rad, Richmond, CA, USA).
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Fig. 1. Plasma concentration (A) and urinary
excretion (B) of F2-isoprostanes, as determined
by gas chromatography/mass spectrometry, in
control rats, diabetic rats, and diabetic rats
treated with diet supplementation of vitamin
E (1000 U/kg diet) four weeks after the onset
of diabetes. Symbols in panel B are: (d) diabe-
tes; (r) diabetes plus vitamin D. *P , 0.05
vs. diabetes; 1P , 0.05 vs. control, N 5 5 in
each group. Time zero values are from control
nondiabetic rats.
adherence, fresh medium was added and collected after Urinary excretion of F2-isoprostanes was increased
24 hours of incubation. N-acetyl-cysteine (5 mmol/L) seven days after the induction of diabetes and remained
was also used for the last 24 hours to determine high- increased during the whole length of our experiment
glucose effect in low oxidative stress conditions. (Fig. 1). Vitamin E-supplemented rats showed signifi-
In both sets of experiments, F2-isoprostanes were quan- cantly less F2-isoprostane urinary excretion (N 5 5, P ,
titated by measuring 8-epi-PGF2a in cell supernatant us- 0.05), although their levels were still above basal values
ing the Oxford Biomedical Research Immunoassay kit at each time point (Fig. 1).
(Oxford, MI, USA). Cells were also scraped, and protein As can be seen in Figure 2, diabetic rats showed
content was determined using Bio-Rad method to nor- increased proteinuria one week after the onset of the
malize F2-isoprostane values. disease when compared with values from control nondia-
Determination of TGF-b. TGF-b production was mea- betic rats. Vitamin E diet supplementation reduced uri-
sured in supernatant of mesangial and endothelial cells nary protein excretion in diabetic rats, with a significant
after 24 hours or 14 days of high ambient glucose incuba- reduction being reached after three weeks of treatment
tion. N-acetyl-cysteine and indomethacin effects were (Fig. 2) when compared with untreated diabetic rats.
also assayed. Blood urea nitrogen (BUN) values were also higher in
In a separate set of experiments, cells were incubated diabetic rats when compared with controls. Once more,
in presence of 8-iso-PGF2a (0.1 mmol/L) for 24 hours, vitamin E supplementation reduced BUN values in dia-
and TGF-b production was measured as follows: Condi- betic rats to levels similar to basal ones (Fig. 2).
tioned media were frozen at 2208C until assayed by a Glomerular expression of TGF-b1 was also deter-
sandwich ELISA after acid activation, as described pre- mined four weeks after the onset of diabetes. As de-
viously in this article. Final concentrations are reported scribed previously, diabetic rats showed significantly in-
per total cell protein content (Bio-Rad, Richmond, creased levels of TGF-b1, as determined by ELISA, when
CA, USA).
compared with control animals (P , 0.05; Fig. 3). Dietary
supplementation with vitamin E significantly reducedStatistics
glomerular TGF-b1 expression (Fig. 3).Data from cell culture experiments, plasma F2-isopros-
tane concentration, and TGF-b glomerular expression In vitro studies
were analyzed using analysis of variance (ANOVA) and
F2-isoprostane production. High ambient glucose (450Student’s t-test. Data from in vivo experiments were
mg/dL) increased F2-isoprostane production in both glo-analyzed using two-way ANOVA. Differences were con-
merular mesangial and endothelial cells after 24 hours ofsidered significant when P , 0.05.
incubation (P , 0.05 vs. normal glucose, N 5 12; Fig. 4).
The effect was totally abolished by coincubation with
RESULTS the antioxidant N-acetyl-cysteine (5 mmol/L), but it was
In vivo studies unaffected by the cyclooxygenase inhibitor indometha-
cin (0.1 mmol/L), suggesting that enzymatically derivedAs can be seen in Figure 1, plasma F2-isoprostane
prostanoid synthesis was not involved in the high ambientlevels in streptozotocin-induced diabetic rats were sig-
glucose effect (Fig. 4). When D-mannitol (350 mg/dL)nificantly higher than in nondiabetic animals (N 5 5,
was used as osmotic control, mesangial cells did not showP , 0.05). Treatment with vitamin E sharply reduced
plasma F2-isoprostanes to basal levels. any increase in F2-isoprostane production (normal glu-
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Fig. 2. Daily urinary protein excretion (A)
and BUN levels (B) in control rats, diabetic
rats (d), and diabetic rats treated with diet
supplementation of vitamin E (1000 U/kg diet;
r) four weeks after the onset of diabetes.
*P , 0.05 vs. diabetes, N 5 5 in each group
and each time point. Time zero values are
from control nondiabetic rats.
cysteine in order to inhibit isoprostane production, TGF-b1
levels in supernatant were similar to those in normal
glucose-treated cells. On the other hand, high ambient
glucose for 24 hours had no significant effect on TGF-b1
production by glomerular endothelial cells (Fig. 7).
Mesangial cells incubated in high ambient glucose for
14 days also showed an increase in TGF-b1 production
(Fig. 8). This increase was partially reduced by coincuba-
tion with N-acetyl-cysteine for the last 24 hours (Fig. 8).
Glomerular endothelial cells incubated during 14 days in
high ambient glucose showed a small increase in TGF-b1
production when compared with normal glucose-cultured
cells (Fig. 8), although it did not reach statistical signifi-
Fig. 3. Expression of TGF-b1 in total protein extracted from glomeruli cance.
isolated from control rats, diabetic rats, and diabetic rats treated with
diet supplementation of vitamin E (1000 U/kg diet) four weeks after
the onset of diabetes, as measured by ELISA. *P , 0.05 vs. control;
DISCUSSION1P , 0.05 vs. diabetes. N 5 5 in each group.
Our results demonstrate a clear involvement of F2-
isoprostanes in diabetic renal injury. We have shown an
increase in both plasma and urinary levels of F2-isopros-cose 0.50 6 0.17 ng/mg protein; D-mannitol 0.65 6 0.21
tanes in diabetic rats and a decrease of such levels whenng/mg protein, N 5 12, P 5 NS).
rats were supplemented in their diet with an antioxidantF2-isoprostane production was also increased in glo-
(vitamin E, 1000 U/kg diet). In addition, we describedmerular mesangial and endothelial cells kept in high
an improvement in proteinuria in vitamin E-treated dia-ambient glucose for 14 days (Fig. 5). Coincubation with
betic animals. We also described a reduction in glomeru-N-acetyl-cysteine for the last 24 hours abolished high
lar TGF-b1 expression in diabetic animals treated withglucose-induced F2-isoprostane production.
antioxidants. As far as we know, this is the first time thatTGF-b production. When glomerular mesangial cells
an improvement in any manifestation of renal function inwere incubated with 8-iso-PGF2a (0.1 mmol/L), TGF-b1
diabetic animals has been associated with reduced isopros-production was significantly increased, as can be seen in
tane synthesis.Figure 6 (N 5 12, P , 0.05). On the other hand, glomeru-
Oxidative stress has been described as one of thelar endothelial cells incubated in the presence of 8-iso-
pathogenic mechanisms that contribute to tissue damagePGF2a showed an increase in TGF-b1 production that
during diabetic nephropathy [15, 16]. The use of antioxi-did not reach statistical significance, although superna-
dants has been reported to improve some of the featurestant TGF-b1 levels were higher than in normal glucose-
of diabetes, such as lipid peroxidation, vascular perme-treated cells (Fig. 6).
ability, and cross-linking of collagen [36]. In addition,Incubation with high ambient glucose for 24 hours in-
taurine treatment has been shown to ameliorate long-creased TGF-b production by mesangial cells (Fig. 7). This
term renal complications of diabetes, such as glomerulareffect has been described previously [2, 6, 8]. When mes-
angial cells were coincubated with antioxidant N-acetyl- hypertrophy, proteinuria, and glomerulosclerosis [16]. It
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Fig. 4. Production of 8-iso-PGF2a in super-
natant of murine mesangial cells (A) and rat
glomerular endothelial cells (B) after 24 hours
of incubation in high ambient glucose, as mea-
sured by ELISA. Abbreviations are: NG, nor-
mal glucose 100 mg/dL; HG, high glucose 450
mg/dL; NAC, N-acetyl-cysteine 5 mmol/L;
Indo, indomethacin 0.1 mmol/L. *P , 0.05 vs.
NG; 1P , 0.05 vs. HG. Each value is the
mean of 12 experiments made in triplicate.
Fig. 5. Twenty-four-hour production of 8-iso-
PGF2a in supernatant of murine mesangial
cells (A) and rat glomerular endothelial cells
(B) after 14 days of incubation in high ambient
glucose, as measured by ELISA. Abbrevia-
tions are: NG, normal glucose 100 mg/dL; HG,
high glucose 450 mg/dL; NAC, N-acetyl-cyste-
ine 5 mmol/L for the last 24 hours. *P , 0.05
vs. NG; 1P , 0.05 vs. HG. Each value is the
mean of 12 experiments made in triplicate.
Fig. 6. Production of TGF-b in the superna-
tant of murine mesangial cells (A) and rat
glomerular endothelial cells (B) after 24 hours
with 8-iso-PGF2a 0.1 mmol/L, as measured
by ELISA. Abbreviations are: Control, cells
incubated with vehicle; Iso, cells incubated
with 0.01 mmol/L 8-iso-PGF2a. *P , 0.05 vs.
control. Each value is the mean of 12 experi-
ments made in triplicate.
is noteworthy that the same study also used vitamin E mode of delivery, duration of the treatment, and pre-
existing conditions of the patients subject of the studywith disappointing results, in clear disagreement with
previous studies showing an improvement in diabetic may account for the different results observed in this
and other clinical trials [38–40]. Compared with our re-complications after vitamin E supplementation [27]. Dif-
ferences in experimental protocols and delivery of vita- sults, the HOPE trial used human subjects with type II
diabetes manifested before the beginning of the treat-min E may account for the discrepancies in the studies.
In this sense, the results of a clinical trial addressing the ment, which lasted for four to six years, while we induced
type I diabetes in rats, and we followed renal functioneffect of vitamin E diet supplementation on cardiovascu-
lar events in high-risk patients (HOPE trial) have been for just four weeks. These differences make it almost
impossible to compare the results obtained.recently published [37]. This study showed no effect of
vitamin E supplementation for four to six years on micro- Our results also reveal an increase in plasma and urine
production of F2-isoprostanes in diabetic animals andvascular complications of diabetes. Once again, dose,
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Fig. 7. Production of TGF-b in supernatant
of murine mesangial cells (A) and rat glomeru-
lar endothelial cells (B) after 24 hours of incu-
bation in high ambient glucose, as measured
by ELISA. Abbreviations are: NG, normal
glucose 100 mg/dL; HG, high glucose 450
mg/dL; NAC, N-acetyl-cysteine 5 mmol/L;
Indo, indomethacin 0.1 mmol/L. *P , 0.05 vs.
NG; 1P , 0.05 vs. HG. Each value is the
mean of 12 experiments made in triplicate.
Fig. 8. Twenty-four hour production of TGF-b
in supernatant of murine mesangial cells (A)
and rat glomerular endothelial cells (B) after
14 days of incubation in high ambient glucose,
as measured by ELISA. Abbreviations are:
NG, normal glucose 100 mg/dL; HG, high glu-
cose 450 mg/dL; NAC, N-acetyl-cysteine 5
mmol/L. *P , 0.05 vs. NG; 1P , 0.05 vs. HG.
Each value is the mean of 12 experiments
made in triplicate.
confirm previous observations reporting an increase of Vitamin E treatment may also reduce other oxidant
stress-related molecules, and this decrease may have anplasma and urine isoprostane concentration in diabetic
patients [27, 28]. A similar increase has been also reported effect on renal function. In fact, vitamin E treatment has
been associated with improvements in several complica-in obese Zucker rats [29]. These studies regard increased
isoprostane synthesis as a marker of increased oxidative tions of diabetes mellitus [41, 42] and other diseases in
which oxidant stress has been described to play a rolestress in diabetic individuals. In this sense, the decrease
in isoprostane levels after several types of treatments, such [43]. In some cases, vitamin E’s effect has been also
associated with a decrease in isoprostane generation [43].as antioxidant supplementation and/or improved meta-
bolic control, has not been considered as being responsi- Renal effects of isoprostane include renal vasocon-
striction that was not associated with any alteration inble for the improvement observed in disease manifesta-
tions, but as a reflection of effective antioxidant therapy. systemic blood pressure [44], cell proliferation, and in-
duction of endothelin-1 gene expression [21, 22, 45]. TheseIn our experimental conditions, vitamin E supplemen-
tation abolished the increases in plasma levels of isopros- effects are exerted though activation of specific receptors
or through activation of thromboxane A2 (TxA2) receptor,tanes in diabetic animals, but only partially decreased
urinary excretion of isoprostanes. This discrepancy may since they are abolished by pharmacological concentra-
tions of SQ29548, a TxA2 receptor antagonist [21, 46, 47].be explained by the fact that the glomerulus is one of
the main sites for isoprostane synthesis in pathological Finally, vitamin E supplementation is associated with
a decrease in glomerular expression of TGF-b1. TGF-bconditions. We can assume that antioxidant treatment
is enough to reduce isoprostane synthesis in other tissues, has been described as the main mediator of synthesis of
extracellular matrix in response to high glucose. More-thus reducing plasma concentration, but the treatment
only partially reduces glomerular synthesis, and these over, previous work by our collaborator, Dr. Ziyadeh,
has shown that treatment in vivo of diabetic mice withincreased glomerular levels are reflected in an increased
urinary excretion. Interestingly, the magnitude of the monoclonal antibodies anti–TGF-b significantly attenu-
ates glomerular and renal overexpression of extracellularreduction in isoprostane excretion is similar to the reduc-
tion in proteinuria observed in diabetic rats treated with matrix proteins, strongly suggesting that the diabetic
state is characterized by increased renal bioactivity ofantioxidants, suggesting a close relationship between both
effects. TGF-b [11]. In our experimental conditions, glomerular
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sclerosis is absent, given the short time (4 weeks) chosen glucose are responsible for the increased TGF-b produc-
tion. After 14 days of treatment, coincubation with anti-for our experiments, but the increases observed in TGF-b1
expression indicate a possible induction of extracellular oxidants for the last 24 hours significantly reduced, but
not completely abolished, the effect of high glucose, sug-matrix synthesis during the later stages of the disease.
The reduction observed in glomerular TGF-b1 expres- gesting that some additional mechanism is involved in
the expression of TGF-b in response to high ambientsion in rats treated with vitamin E indicates a beneficial
effect of antioxidants, which may reduce the synthesis glucose. Our in vitro results are in agreement with the
in vivo observation describing a reduction of glomerularof TGF-b through the reduction in isoprostane synthesis,
as suggested by our in vitro results, as explained later in TGF-b1 expression in rats treated with vitamin E, treat-
ment that is associated with a reduction in isoprostanethis article.
Our study also describes the effect of high ambient synthesis.
The mechanisms involved in TGF-b expression in re-glucose on isoprostane synthesis in vitro by renal glomeru-
lar cells. Our results show that high ambient glucose (450 sponse to isoprostane require further studies. It has been
suggested that activation of PKC is involved in TGF-bmg/dL) increases isoprostane synthesis in both mesangial
and endothelial cells. A similar result was previously re- expression in response to high glucose [12–14]. We have
described that isoprostanes increase diacylglycerol andported in smooth muscle cells [31]. The effect is observed
after 24 hours or 14 days of incubation in high ambient inositol trisphosphate turnover in endothelial cells [45],
which in turn could activate PKC and subsequently in-glucose, and it is not affected by the cyclooxygenase in-
hibitor indomethacin, showing that in our experimental crease TGF-b expression.
The effects of antioxidants have been previously stud-conditions, cyclooxygenase does not play a role in iso-
prostane synthesis, despite previous reports showing an ied in high-glucose conditions in vitro. Vitamin E de-
creases lipid peroxide levels in mesangial cells culturedinvolvement of this enzyme in isoprostane synthesis in
vivo and in vitro [48, 49]. in high ambient glucose and reduces glucose-induced
overproduction of fibronectin [30]. Vitamin E has alsoThe increase in F2-isoprostane is completely abolished
by the antioxidant N-acetyl-cysteine, which acts as a scav- been shown to reduce diacylglycerol and PKC activity
in membrane fractions [30] and to reverse the antiprolif-enger of reactive oxygen free radicals, suggesting that
isoprostanes are synthesized by an interaction of free erative effect of high glucose on mesangial cells [50].
Increased isoprostanes may influence diabetic nephrop-radicals with arachidonic acid.
Cell culture has been widely used to define the role athy by mechanisms other than increases in TGF-b syn-
thesis. We have recently described that isoprostanesof hyperglycemia in the pathological manifestation of dia-
betic nephropathy. In this sense, incubation of renal cells induce endothelial cell proliferation and increase endo-
thelin-1 gene expression [45], which has been describedin high ambient glucose has defined a role for TGF-b as
the main mediator of high-glucose effects on renal cells. to play a role in streptozotocin-induced diabetic ne-
phropathy. Increased levels of endothelin mRNA haveHigh ambient glucose leads to the activation and expres-
sion of TGF-b in glomerular cells [2, 4, 6, 9], and this been described in glomeruli from streptozotocin-induced
diabetic rats [51], and urinary levels of endothelin-1 areincreased expression is responsible for hypertrophic and
prosclerotic effects of high glucose concentrations [11], elevated in type I diabetic BB rats [52]. Furthermore,
endothelin receptor antagonists attenuate glomerularas well as for the synthesis of extracellular matrix compo-
nents such as collagen, fibronectin, and proteoglycans hyperfiltration and urinary protein excretion and de-
crease glomerular collagen mRNA levels [53].[4, 6, 9].
Our results indicate that F2-isoprostanes significantly High ambient glucose increases F2-isoprostane synthe-
sis in glomerular cells, and this increased isoprostaneincrease TGF-b1 production in mesangial cells, but the
same effect did not reach statistical significance in endo- concentration may be responsible, in part, for the in-
crease in TGF-b that has been described in vivo in dia-thelial cells after 24 hours of incubation. High ambient
glucose for 14 days also induced an increase in TGF-b betic animals. Despite the lack of statistical significance
of the effect of high ambient glucose on TGF-b produc-production in endothelial cells, but this effect was not
statistically significant. Recently, it has been described tion in endothelial cells, these cells may contribute also
in an indirect way to the synthesis of TGF-b, since theirthat high ambient glucose increases TGF-b expression by
glomerular endothelial cells, although the experimental increased production of isoprostane may also act in a
paracrine manner on mesangial cells, increasing totalconditions described are different from the ones used in
the present work (abstract; Han et al, J Am Soc Nephrol glomerular TGF-b production (Fig. 9).
It has been recently suggested that it is difficult to10:681, 1999).
Coincubation with antioxidants completely abolished relate in vitro and in vivo effects of isoprostanes, given
the large number of compounds that are formed underthe effect of glucose at 24 hours, suggesting that the
F2-isoprostanes being synthesized in response to high conditions of oxidant stress in vivo [54]. However, taken
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Fig. 9. Proposed model summarizing the in-
teractions between isoprostane and TGF-b
production by glomerular cells in response to
high ambient glucose. While high ambient glu-
cose drives F2-isoprostane formation in both
mesangial and endothelial cells, the predomi-
nant source of TGF-b is the mesangial cell,
on which F2-isoprostanes act in an autocrine
and paracrine fashion.
2. Wolf G, Sharma K, Chen Y, Ericksen M, Ziyadeh FN: Hightogether, our in vivo and in vitro results strongly suggest
glucose-induced proliferation in mesangial cells is reversed by auto-
a role for isoprostanes in diabetic nephropathy, other crine TGF-b. Kidney Int 42:647–652, 1992
than serving as mere markers of oxidant stress. We have 3. Ziyadeh FN, Han DC, Cohen JA, Guo J, Cohen MP: Glycated
albumin stimulates fibronectin gene expression in glomerular mes-used 8-epi-PGF2a for our in vitro experiments since this
angial cells: Involvement of the transforming growth factor-b sys-compound is the most abundant isoprostane in vivo [20], tem. Kidney Int 53:631–638, 1998
and we have previously described its effects in renal 4. Ziyadeh FN, Sharma K, Ericksen M, Wolf G: Stimulation of
collagen gene expression and protein synthesis in murine mesangialfunction [44].
cells by high glucose is mediated by autocrine activation of trans-In conclusion, our results demonstrate that antioxidant forming growth factor-b. J Clin Invest 93:536–542, 1994
treatment improves early manifestations of diabetic ne- 5. Ziyadeh FN, Snipes ER, Watanabe M, Alvarez RJ, Goldfarb S,
Haverty TP: High glucose induces cell hypertrophy and stimulatesphropathy, such as proteinuria. This improvement is as-
collagen gene transcription in proximal tubule. Am J Physiolsociated with a decrease in plasma and urinary levels 259:F704–F714, 1990
of F2-isoprostanes. We have also demonstrated a link 6. Sharma K, Ziyadeh FN: Hyperglycemia and diabetic kidney dis-
ease: The case for transforming growth factor-beta as a key media-between isoprostanes and high glucose-induced expres-
tor. Diabetes 44:1139–1146, 1995sion of TGF-b. Our results provide the basis for under-
7. Hoffman BB, Sharma K, Ziyadeh FN: Potential role of TGF-b
standing the mechanisms involved in the effect of antioxi- in diabetic nephropathy. Miner Electrolyte Metab 24:190–196, 1998
8. Rocco MV, Chen Y, Goldfarb S, Ziyadeh FN: Elevated glucosedants in diabetes mellitus, and they open the field to
stimulates TGF-beta gene expression and bioactivity in proximalassay other therapeutic tools, such as TxA2 antagonists,
tubule. Kidney Int 41:107–114, 1992
which partially inhibit the effects of isoprostanes in vitro. 9. van Det NF, Verhagen NA, Tamsma JT, Berden JH, Bruijn JA,
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